Whit Mayo Analyst PerformanceSenior Managing Director & Senior Research Analyst at Leerink PartnersWhit Mayo is a stock analyst at Leerink Partners focused in the medical sector, covering 30 publicly traded companies. Over the past year, Whit Mayo has issued 12 stock ratings, including buy and hold recommendations. While full access to Whit Mayo's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Whit Mayo's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings78 Last 10 YearsBuy Recommendations56.41% 44 Buy RatingsCompanies Covered30 Unique Companies Ratings Distribution78RatingsDistribution of strong buy, buy, hold, and sell ratings by Whit Mayo.RatingPercentageCount Strong Buy0.0%0 ratings Buy56.4%44 ratings Hold42.3%33 ratings Sell1.3%1 ratingsOut of 78 total stock ratings issued by Whit Mayo at Leerink Partners, the majority (56.4%) have been Buy recommendations, followed by 42.3% Hold and 1.3% Sell.Best & Worst CallsBest Call0000.0%EVHCMay 2016Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%AHCONov 2022Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNYSE66.7% of companies on NYSE20 companiesNASDAQ33.3% of companies on NASDAQ10 companiesWhit Mayo, an analyst at Leerink Partners, currently covers 30 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.Coverage FocusSector IconSectorPercentageMedical22 companies73.3%Finance5 companies16.7%Miscellaneous2 companies6.7%Business Services1 company3.3%Whit Mayo of Leerink Partners specializes in stock coverage within the Medical sector, with additional focus on Finance and companies.Coverage IndustriesIndustryPercentageMED - HOSPITALS5 companies16.7%MED - OUTP/HM CRE5 companies16.7%MEDICAL SERVICES3 companies10.0%MED - HMO3 companies10.0%FIN - INVEST BKRS2 companies6.7%BANKS - MJR REGNL2 companies6.7%Miscellaneous2 companies6.7%TECHNOLOGY SERVICES1 company3.3%BANKS - SOUTHEAST1 company3.3%MED PRODUCTS1 company3.3%HOME HEALTH CARE SERVICES1 company3.3%GENERAL MEDICAL & SURGICAL HOSPITALS1 company3.3%OFFICES & CLINICS OF MEDICAL DOCTORS1 company3.3%SOCIAL SERVICES1 company3.3%MED INSTRUMENTS1 company3.3% About Whit MayoWhit Mayo is a Senior Managing Director and Senior Research Analyst covering Healthcare Providers & Managed Care at Leerink Partners. He leads Leerink Partners’ research across payors, providers, and health systems and provides strategic guidance and insight for our clients and partners. Whit joined the Firm in 2021 from UBS, where he most recently served as Managing Director. Prior to that, Whit covered the sector at Baird and Stephens, Inc. In 2020 he was ranked in Institutional Investor’s All-America Research Team within the Health Care Facilities & Managed Care category. He earned his Bachelor of Arts in Economics at Sewanee, The University of the South.Follow on LinkedIn Whit Mayo's Ratings History at Leerink Partners Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export to Excel CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsMDPediatrix Medical Group9/5/2025Boost Price Target$16.99$17.00Market Perform$0.0000.00% ROIELVElevance Health7/18/2025Reiterated Rating$301.33$310.00Market Perform$0.0000.00% ROIMSMorgan Stanley7/8/2025Boost Price Target$143.76$145.00Equal Weight$0.0000.00% ROIFITBFifth Third Bancorp6/10/2025Boost Price Target$39.57$52.00Overweight$0.0000.00% ROIFITBFifth Third Bancorp4/21/2025Lower Price Target$33.38$48.00Overweight$0.0000.00% ROIAIRSAirSculpt Technologies3/31/2025Lower Price Target$2.27$2.50Market Perform$0.0000.00% ROIRFRegions Financial3/28/2025Lower Price Target$21.61$26.00Equal Weight$0.0000.00% ROIPNCThe PNC Financial Services Group3/28/2025Lower Price Target$173.19$230.00Overweight$0.0000.00% ROIFITBFifth Third Bancorp3/28/2025Lower Price Target$39.13$50.00Overweight$0.0000.00% ROIBKBank of New York Mellon3/3/2025Boost Price Target$89.50$96.00Equal Weight$0.0000.00% ROIAHCOAdaptHealth2/13/2025Lower Price Target$8.87$11.00Buy$0.0000.00% ROIBKBank of New York Mellon1/16/2025Boost Price Target$81.44$86.00Equal Weight$0.0000.00% ROI Stock Forecasts and Research Tools Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.